Literature DB >> 15734900

Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action.

M O Urban1, K Ren, K T Park, B Campbell, N Anker, B Stearns, J Aiyar, M Belley, C Cohen, L Bristow.   

Abstract

The anticonvulsant gabapentin (GBP) has been shown effective for the treatment of neuropathic pain, although its mechanism of action remains unclear. A recent report has suggested that binding to the alpha(2)delta subunit of voltage-gated calcium channels contributes to its antinociceptive effect, based on the stereoselective efficacy of two analogs: (1S,3R)3-methylgabapentin (3-MeGBP) (IC(50) = 42 nM), which is effective in neuropathic pain models; and (1R,3R)3-MeGBP (IC(50) > 10,000 nM), which is ineffective (Field et al., 2000). The present study was designed to further examine the profiles of GBP and 3-MeGBP in rat models of acute and persistent pain. Systemic administration of GBP or (1S,3R)3-MeGBP inhibited tactile allodynia in the spinal nerve ligation model of neuropathic pain, whereas (1R,3R)3-MeGBP was ineffective. The antiallodynic effect of GBP, but not (1S,3R)3-MeGBP, was blocked by i.t. injection of the GABA(B) receptor antagonist [3-[[(3,4-dichlorophenyl)methyl]amino]propyl](diethoxymethyl)phosphinic acid (CGP52432). Systemic GBP or (1S,3R)3-MeGBP also inhibited the second phase of formalin-evoked nociceptive behaviors, whereas (1R,3R)3-MeGBP was ineffective. However, both (1S,3R)3-MeGBP and (1R,3R)3-MeGBP, but not GBP, inhibited first phase behaviors. In the carrageenan model of inflammatory pain, systemic GBP or (1R,3R)3-MeGBP failed to inhibit thermal hyperalgesia, whereas (1S,3R)3-MeGBP had a significant, albeit transient, effect. Systemic (1S,3R)3-MeGBP, but not GBP or (1R,3R)3-MeGBP, also produced an antinociceptive effect in the warm water tail withdrawal test of acute pain. These data demonstrate that GBP and 3-MeGBP display different antinociceptive profiles, suggesting dissimilar mechanisms of antinociceptive action. Thus, the stereoselective efficacy of 3-MeGBP, presumably related to alpha(2)delta binding, likely does not completely account for the mechanism of action of GBP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734900     DOI: 10.1124/jpet.104.081778

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

2.  α2δ-1-Bound N-Methyl-D-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents.

Authors:  Meichun Deng; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  Anesthesiology       Date:  2019-05       Impact factor: 7.892

3.  Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.

Authors:  Misty D Smith; Jose H Woodhead; Laura J Handy; Timothy H Pruess; Fabiola Vanegas; Erin Grussendorf; Joel Grussendorf; Karen White; Karolina K Bulaj; Reisa K Krumin; Megan Hunt; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-05-15       Impact factor: 3.996

4.  Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.

Authors:  Aryeh I Herman; Andrew J Waters; Sherry A McKee; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

5.  A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Authors:  T G Tzellos; G Papazisis; K A Toulis; Ch Sardeli; D Kouvelas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

6.  Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation.

Authors:  Chun-Ying Li; Xiu-Lin Zhang; Elizabeth A Matthews; Kang-Wu Li; Ambereen Kurwa; Amin Boroujerdi; Jimmy Gross; Michael S Gold; Anthony H Dickenson; Guoping Feng; Z David Luo
Journal:  Pain       Date:  2006-06-09       Impact factor: 6.961

7.  Spontaneous Chronic Pain After Experimental Thoracotomy Revealed by Conditioned Place Preference: Morphine Differentiates Tactile Evoked Pain From Spontaneous Pain.

Authors:  Ching-Hsia Hung; Jeffrey Chi-Fei Wang; Gary R Strichartz
Journal:  J Pain       Date:  2015-06-24       Impact factor: 5.820

8.  Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.

Authors:  W Xiao; A Boroujerdi; G J Bennett; Z D Luo
Journal:  Neuroscience       Date:  2006-11-02       Impact factor: 3.590

9.  TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Authors:  Jérôme Busserolles; Ismail Ben Soussia; Laetitia Pouchol; Nicolas Marie; Mathieu Meleine; Maïly Devilliers; Céline Judon; Julien Schopp; Loïc Clémenceau; Laura Poupon; Eric Chapuy; Serge Richard; Florence Noble; Florian Lesage; Sylvie Ducki; Alain Eschalier; Stéphane Lolignier
Journal:  Br J Pharmacol       Date:  2020-09-21       Impact factor: 8.739

10.  TRPA1 mediates formalin-induced pain.

Authors:  Colleen R McNamara; Josh Mandel-Brehm; Diana M Bautista; Jan Siemens; Kari L Deranian; Michael Zhao; Neil J Hayward; Jayhong A Chong; David Julius; Magdalene M Moran; Christopher M Fanger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.